fluorodeoxyglucose f18 has been researched along with Anus Neoplasms in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (17.46) | 29.6817 |
2010's | 37 (58.73) | 24.3611 |
2020's | 15 (23.81) | 2.80 |
Authors | Studies |
---|---|
Adusumilli, P; Casanova, N; Cooper, R; Elsayed, N; Gilbert, A; Samuel, R; Scarsbrook, AF; Theophanous, S; Tolan, DJ | 1 |
Foroudi, F; Joon, DL; Khoo, V; Knight, K; Lau, E; Schneider, M; Sim, J; Smith, D | 1 |
Bates, DDB; Ernst, R; Gangai, N; Golia Pernicka, JS; Gollub, MJ; Hope, TA; Horvat, N; Rauch, GM; Sheedy, SP | 1 |
Fraum, TJ; Hope, TA; Ince, S; Jayaprakasam, VS; Nepal, P; Paspulati, RM; Suman, G | 1 |
Arcadipane, F; Balestra, G; Dinapoli, N; Fato, M; Fiandra, C; Franco, P; Gallio, E; Ricardi, U; Rosati, S; Scaffidi Gennarino, D; Silvetti, P; Zara, S | 1 |
Bell, J; Mac Curtain, BM; Ng, ZQ; O'Mahony, A; Qian, W; Temperly, HC | 1 |
Carré, A; Chargari, C; Classe, M; Deutsch, E; Genestie, C; Guckenberger, M; Guren, MG; La Greca Saint-Esteven, A; Lemanski, C; Malinen, E; McDermott, G; McKenna, J; Niyoteka, S; Robert, C; Rouhi, R; Scarsbrook, A; Seban, RD; Sun, R; Tanadini-Lang, S | 1 |
Acosta Roa, AM; Guren, MG; Hernes, E; Malinen, E; Rekstad, BL; Rusten, E; Skingen, VE; Undseth, C | 1 |
Appelt, AL; Brown, PJ; Currie, S; Frood, R; Gilbert, A; Scarsbrook, A; Sebag-Montefiore, D; Zhong, J | 1 |
Chu, KY; Cooke, R; Hawkins, M; Jacobs, C; Muirhead, R; Ng, S; Robinson, M; Strauss, V; Van den Heuvel, F; Virdee, P | 1 |
Barone, R; Gambacorta, MA; Giordano, A; Leccisotti, L; Manfrida, S; Masiello, V; Privitera, V; Ripani, D; Rufini, V; Tagliaferri, L; Valentini, V | 1 |
Li, W; Li, X; Xia, Z | 1 |
Appelt, A; Brown, P; Scarsbrook, A; Sebag-Montefiore, D | 1 |
Kiyota, T; Matsumoto, S; Otsuka, K; Sena, Y; Silman, C | 1 |
Bagni, O; Filippi, L; Fontana, A; Rossi, L; Spinelli, GP | 1 |
Buchwald, P; Frennered, A; Johnsson, A; Nilsson, MP; Sartor, H; Scherman, J; Trägårdh, E; Zackrisson, S | 1 |
Arcadipane, F; Fiandra, C; Franco, P; Giglioli, FR; Ragona, R; Ricardi, U; Trino, E | 1 |
Cheng, Z; Kuang, D; Song, S; Zhu, X; Zou, S | 1 |
Albertsson, P; Alverbratt, C; Björkander, E; Hallqvist, A; Liljegren, A; Palm, S; Samuelsson, O; Strandell, A | 1 |
Feingold, D; Gaertner, WB; Glasgow, SC; Herzig, DO; Steele, SR; Stewart, DB | 1 |
Cui, Y; Czito, BG; Das, S; Eng, JS; Faught, AM; Higgins, K; Hong, JC; Palta, M; Patel, BN; Rushing, CN; Willett, CG; Yin, FF | 1 |
Ankrah, AO; Kaoma, CA; Lawal, IO; Maes, A; Mokgoro, NP; Mokoala, KMG; Popoola, GO; Sathekge, MM; Van de Wiele, C | 1 |
Aznar, MC; Chu, KY; Cooke, R; Hawkins, MA; Jacobs, C; Muirhead, R; Ng, SM; Sabbagh, A; Strauss, VY; Virdee, PS | 1 |
Dabbagh, VR; Harsini, S; Qodsi Rad, MA; Sadeghi, R; Treglia, G | 1 |
Guren, MG; Hernes, E; Klotz, D; Malinen, E; Rekstad, BL; Rusten, E; Undseth, C | 1 |
Doll, C; Duimering, A; Fairchild, A; Ghosh, S; Joseph, K; MacEwan, R; Mulder, K; Nijjar, T; Nijjar, Y; Riauka, T; Schiller, D; Severin, D; Tankel, K; Usmani, N; Warkentin, H; Wong, C | 1 |
Canevari, C; De Nardi, P; Guarneri, G; Passoni, P; Rosati, R; Slim, N; Tamburini, A | 1 |
Capp, A; Gallagher, S; Holder, C; Hruby, G; Jones, MP; Kumar, M; Martin, J; Metser, U; Oldmeadow, C; Rutherford, N; Sridharan, S | 1 |
Annunziata, S; Ayati, N; Caldarella, C; Giovanella, L; Sadeghi, R; Treglia, G | 1 |
Agarwal, A; Kachnic, LA; Marcus, C; Nene, P; Subramaniam, RM; Xiao, J | 1 |
Hruby, G; Jones, M; Martin, J; Rutherford, N; Solomon, M | 1 |
Brambilla, M; Cena, T; Deantonio, L; Krengli, M; Milia, ME; Perotti, C; Sacchetti, G; Turri, L | 1 |
Allen, JN; Blaszkowsky, LS; Drapek, LC; Hong, TS; Jee, KW; Lee, LK; Murphy, JE; Niemierko, A; Rose, BS; Wang, Y; Wo, JY | 1 |
Burkill, GJ; Dizdarevic, S; Gilbert, DC; Jones, JR; McKinna, F; Teagle, AR | 1 |
Braun, M; Falch, C; Kirschniak, A; Klumpp, B; Koenigsrainer, A; Mueller, S | 1 |
Behrendt, FF; Eble, MJ; Heinzel, A; Mohammadkhani Shali, S; Mottaghy, FM; Schmitt, V; Verburg, FA; Winz, OH | 1 |
Alberini, JL; Cacheux, W; Fayard, J; Gauthé, M; Lièvre, A; Richard-Molard, M | 1 |
Drummond, E; Fay, M; Heriot, AG; Hicks, RJ; Hogg, A; Leong, T; MacKay, J; Milner, A; Ng, M; Ngan, SY; Winton, Ed | 1 |
Dinter, DJ; Haberkorn, U; Hermann, B; Mai, SK; Welzel, G; Wenz, F | 1 |
Bellò, M; Beltramo, G; Cassoni, P; Castellano, I; Contu, V; Mistrangelo, M; Morino, M; Munoz, F; Mussa, A; Pelosi, E; Racca, P; Ricardi, U | 1 |
Betler, J; Day, E; Kirichenko, A; Miften, M; Mohammadi, S; Parda, D; Reitz, B | 1 |
Blackman, G; Bomanji, J; Boulos, PB; Ell, PJ; Engledow, AH; Groves, A; Skipworth, JR; Warren, SJ | 1 |
Bassi, MC; Brambilla, M; Cannillo, B; Deantonio, L; Inglese, E; Krengli, M; Milia, ME; Mones, E; Sacchetti, G; Turri, L | 1 |
Dehdashti, F; Grigsby, PW; Kidd, EA; Siegel, BA | 1 |
Adam, G; Bannas, P; Derlin, T; Frenzel, T; Klutmann, S; Mester, J; Weber, C | 1 |
Bauer, P; de Parades, V; Huchet, V; Kerrou, K; Montravers, F; Talbot, JN; Touboul, E; Vercellino, L | 1 |
Lindskog, DM; Nikkhou, K; Talusan, P | 1 |
Day, FL; Heriot, A; Hicks, RJ; Hogg, A; Leong, T; Link, E; Lynch, C; Michael, M; Moodie, K; Ngan, S; Winton, Ed | 1 |
Fox, BM; Wells, IT | 1 |
Bhuva, NJ; Glynne-Jones, R; Harrison, MK; Sonoda, L; Wong, WL | 1 |
Baccega, M; Bellò, M; Cassoni, P; Cravero, F; Filippini, C; Fora, G; Lesca, A; Milanesi, E; Mistrangelo, M; Morino, M; Munoz, FH; Pelosi, E; Racca, P; Ricardi, U; Skanjeti, A | 1 |
Bydder, GM; Bydder, M; Cornell, M; Einck, J; Fanta, P; Hoh, CK; Lawson, JD; Liang, Y; Mell, LK; Mundt, AJ; Rose, BS; Saenz, C; Yashar, CM | 1 |
Carrington, BM; Kochhar, R; Plumb, AA; Saunders, M | 1 |
Kim, BS | 1 |
Krajewski, KM; Ramaiya, N; Saboo, SS; Shinagare, AB; Zukotynski, K | 1 |
Abbey, E; Birnbaum, EH; Cotter, SE; Dehdashti, F; Dietz, DW; Fleshman, JW; Grigsby, PW; Hunt, SR; Kodner, IJ; Lowney, JK; Malyapa, RS; Mutch, MG; Myerson, RJ; Siegel, BA; Tan, B; Wang, X | 1 |
Gambhir, SS; Niederkohr, RD | 1 |
Nguyen, BD; Ram, PC; Roarke, MC | 1 |
Bourguet, P; Metges, JP; Mitry, E; Monteil, J; Planchamp, F; Tubiana-Mathieu, N | 1 |
Anderson, C; Esiashvili, N; Esteves, F; Fowler, Z; Fox, T; Ghavidel, S; Godette, K; Koshy, M; Landry, J; Staley, C | 1 |
Chiou, JF; Hsu, CH; Lin, SE; Tai, CJ; Wu, CH | 1 |
Dehdashti, F; Fleshman, JW; Grigsby, PW; Myerson, RJ; Schwarz, JK; Siegel, BA | 1 |
Chao, M; Feigen, M; Joon, DL; Joon, ML; Kai, C; Khoo, V; Nguyen, BT; Quong, G; Rykers, K; Scott, A; See, A; Wada, M; Zupan, E | 1 |
11 review(s) available for fluorodeoxyglucose f18 and Anus Neoplasms
Article | Year |
---|---|
Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Expert Testimony; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiology | 2023 |
PET/MRI in colorectal and anal cancers: an update.
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Pre- and post-treatment FDG PET-CT as a predictor of patient outcomes in anal squamous cell carcinoma: A systematic review and meta-analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies | 2023 |
Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis.
Topics: Anus Neoplasms; Chemoradiotherapy; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Quality of Life; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted | 2018 |
Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Prognosis; Survival Analysis; Tumor Burden | 2018 |
Diagnostic performance of positron emission tomography/computed tomography using fluorine-18 fluorodeoxyglucose in detecting locoregional nodal involvement in patients with anal canal cancer: a systematic review and meta-analysis.
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
FDG PET/CT in the management of colorectal and anal cancers.
Topics: Adult; Aged; Anus Neoplasms; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
The Role of FDG-PET in the Initial Staging and Response Assessment of Anal Cancer: A Systematic Review and Meta-analysis.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome | 2015 |
Imaging of anal carcinoma.
Topics: Anus Neoplasms; Chemoradiotherapy; Endoscopy, Gastrointestinal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Anal carcinoma: FDG PET/CT in staging, response evaluation, and follow-up.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Treatment Outcome | 2013 |
[Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Topics: Anus Neoplasms; Bile Duct Neoplasms; Colorectal Neoplasms; Digestive System Neoplasms; Endocrine Gland Neoplasms; Esophageal Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Intestine, Large; Liver Neoplasms; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms | 2007 |
4 trial(s) available for fluorodeoxyglucose f18 and Anus Neoplasms
Article | Year |
---|---|
Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence.
Topics: Anus Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Recurrence; Treatment Outcome | 2018 |
Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Body Burden; Female; Fluorodeoxyglucose F18; Groin; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiation Protection; Radiopharmaceuticals; Radiotherapy, Conformal; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
The role of ¹⁸fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Tomography, X-Ray Computed | 2011 |
FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Tomography, X-Ray Computed | 2010 |
48 other study(ies) available for fluorodeoxyglucose f18 and Anus Neoplasms
Article | Year |
---|---|
Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Epithelial Cells; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2022 |
A pilot study investigating the role of
Topics: Anus Neoplasms; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Pilot Projects; Radiopharmaceuticals | 2022 |
Active bone marrow segmentation based on computed tomography imaging in anal cancer patients: A machine-learning-based proof of concept.
Topics: Anus Neoplasms; Bone Marrow; Fluorodeoxyglucose F18; Humans; Machine Learning; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2023 |
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Human Papillomavirus Viruses; Humans; Papillomavirus Infections; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer.
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Retrospective Studies; Tumor Burden | 2023 |
Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Kaplan-Meier Estimate; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer.
Topics: Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Pelvis; Radiotherapy, Intensity-Modulated | 2020 |
The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.
Topics: Anus Neoplasms; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies | 2020 |
Radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
In reply to letter to the editor: radiomic feature analysis of pre-treatment FDG PET-CT for predicting outcome in anal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2020 |
Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Anal Canal; Anus Neoplasms; Biological Transport; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2020 |
Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Treatment Outcome; Tumor Burden | 2020 |
Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lymph Nodes; Lymphatic Metastasis; Neoplasm Staging; Pelvis; Positron Emission Tomography Computed Tomography | 2021 |
Incorporating
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pelvic Bones; Positron-Emission Tomography; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results | 2017 |
Anal Malignant Melanoma Manifesting Hepatic Metastases Shown on FDG PET/CT.
Topics: Adult; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Melanoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2018 |
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018).
Topics: Ablation Techniques; Administration, Topical; Aftercare; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biopsy; Carcinoma, Squamous Cell; Chemoradiotherapy; Colorectal Surgery; Early Detection of Cancer; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Papanicolaou Test; Papillomavirus Infections; Papillomavirus Vaccines; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Societies, Medical; Survival Rate | 2018 |
Prognostic Value of Pre-treatment F-18 FDG PET Metabolic Metrics in Patients with Locally Advanced Carcinoma of the Anus with and without HIV Infection.
Topics: Adult; Age Factors; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Follow-Up Studies; HIV; HIV Infections; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate | 2018 |
Is There a Role for an 18F-fluorodeoxyglucose-derived Biological Boost in Squamous Cell Anal Cancer?
Topics: Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies | 2019 |
Anal cancer chemoradiotherapy outcome prediction using
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Papillomaviridae; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Tumor Burden | 2019 |
Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Topics: Adult; Aged; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden | 2019 |
Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer.
Topics: Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2019 |
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
Topics: Adult; Aged; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated | 2019 |
Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Biopsy; Chemoradiotherapy; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation.
Topics: Adult; Aged; Antineoplastic Agents; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cohort Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Linear Models; Male; Middle Aged; Mitomycin; Neutropenia; Pelvic Bones; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2016 |
Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; False Negative Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Positron Emission Tomography Computed Tomography; Recurrence; Retrospective Studies | 2016 |
Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT.
Topics: Aged; Anal Canal; Anus Neoplasms; Colon, Sigmoid; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Patient Selection; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rectal Neoplasms; Rectum; Retrospective Studies; Treatment Outcome | 2016 |
Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma; Chemoradiotherapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Forecasting; Humans; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Survival Rate; Tumor Burden | 2016 |
Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Female; Fluorodeoxyglucose F18; France; Humans; Longitudinal Studies; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity | 2009 |
Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2010 |
A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients.
Topics: Algorithms; Anus Neoplasms; Artificial Intelligence; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Anal cancer maximum F-18 fluorodeoxyglucose uptake on positron emission tomography is correlated with prognosis.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals | 2010 |
Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
Topics: Adult; Aged; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Inguinal Canal; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Retrospective Studies; Salvage Therapy; Tomography, X-Ray Computed | 2011 |
Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2011 |
False-positive positron emission tomography in patients with history of malignancy.
Topics: Adult; Anus Neoplasms; Biopsy; Breast Neoplasms; Carcinoma; Carcinoma, Lobular; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Granular Cell Tumor; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Medical Oncology; Melanoma; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Recurrence; Skin Neoplasms; Tomography, X-Ray Computed | 2011 |
FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Australia; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Confounding Factors, Epidemiologic; Disease-Free Survival; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Proportional Hazards Models; Radiopharmaceuticals; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Outcome | 2011 |
PET/CT in anal cancer - is it worth doing?
Topics: Anus Neoplasms; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
To PET or not to PET? That is the question. Staging in anal cancer.
Topics: Anus Neoplasms; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed | 2012 |
Role of positron emission tomography-computed tomography in the management of anal cancer.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Digital Rectal Examination; False Positive Reactions; Female; Fluorodeoxyglucose F18; Fluorouracil; Follow-Up Studies; Humans; Inguinal Canal; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Proctoscopy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed | 2012 |
Prospective study of functional bone marrow-sparing intensity modulated radiation therapy with concurrent chemotherapy for pelvic malignancies.
Topics: Adipose Tissue; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Chemoradiotherapy; Cisplatin; Feasibility Studies; Female; Fluorodeoxyglucose F18; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Multimodal Imaging; Organ Sparing Treatments; Pelvis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden; Uterine Cervical Neoplasms | 2013 |
The 18F-FDG PET/CT finding of a condyloma acuminata mimicking primary anorectal carcinoma in an HIV-infected patient.
Topics: Adult; Anus Neoplasms; Condylomata Acuminata; Diagnosis, Differential; Fluorodeoxyglucose F18; HIV Infections; Humans; Male; Positron-Emission Tomography; Rectal Neoplasms; Tomography, X-Ray Computed | 2013 |
FDG-PET/CT in the evaluation of anal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Female; Fluorodeoxyglucose F18; HIV Seropositivity; Humans; Inguinal Canal; Lymph Nodes; Male; Middle Aged; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Tomography, X-Ray Computed | 2006 |
F-18 FDG PET/CT imaging of extramammary Paget disease of the perianal region.
Topics: Anus Neoplasms; Biopsy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteitis Deformans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2006 |
F-18 FDG PET/CT imaging of anal canal squamous cell carcinoma.
Topics: Anus Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
PET-CT fusion in radiation management of patients with anorectal tumors.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Conformal; Rectal Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2007 |
FDG uptake in a rectal malignant melanoma.
Topics: Adult; Anus Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Melanoma; Positron-Emission Tomography; Radiography; Radiopharmaceuticals | 2007 |
Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2008 |
Assessing the impact of FDG-PET in the management of anal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anus Neoplasms; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals | 2008 |